skip navigation

logo-colorGenzada Pharmaceuticals USA, Inc.

  • Home
  • About Us
  • Research
  • Patients
  • News
  • Contact Us

March 20, 2019

Drug Development

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02 from Genzada Pharmaceuticals

Read More

November 20, 2018

FDA Approval

Kansas Company Receives FDA Approval on Plant Derived Cancer Treatment

Read More
Contact Us

620.204.7150

Genzada Pharmaceuticals USA, Inc.

517 E 30th Ave
STE E
Hutchinson, KS 67502

info@genzada.com

© 2023 Genzada Pharmaceuticals USA, Inc., All Rights Reserved. Terms of Use and Privacy Policy